XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Earnings Per Share | 3 Months Ended
--- | ---
Dec. 29, 2023
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share Basic EPS is computed by dividing net income attributable to Dolby Laboratories, Inc. by the number of weighted-average shares of Class A and Class B common stock outstanding during the period. Through application of the treasury stock method, diluted EPS is computed in the same manner, except that the number of weighted-average shares outstanding is increased by the number of potentially dilutive shares from employee incentive plans during the period. Basic and diluted EPS are computed independently for each fiscal quarter and year-to-date period, which involves the use of different weighted-average share count figures relating to quarterly and annual periods. As a result, and after factoring the effect of rounding to the nearest cent per share, the sum of all four quarter-to-date EPS figures may not equal year-to-date EPS. Potentially dilutive shares represent the hypothetical number of incremental shares issuable under the assumed exercise of outstanding stock options (both vested and unvested) and vesting of outstanding RSUs. The calculation of dilutive shares outstanding excludes securities that would have an antidilutive effect on EPS. The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts):
| Fiscal Quarter Ended |  |
| December 29, 2023 | December 30, 2022 |  |  |  |
Numerator: |  |  |  |  |  |
Net income attributable to Dolby Laboratories, Inc. | $ | 66,981 |  | $ | 79,375 |  |  |  |  |
Denominator: |  |  |  |  |  |
Weighted-average shares outstanding—basic | 95,376 |  | 95,905 |  |  |  |  |
Potential common shares from options to purchase common stock | 755 |  | 533 |  |  |  |  |
Potential common shares from restricted stock units | 1,289 |  | 566 |  |  |  |  |
Potential common shares from employee stock purchase plan | 19 |  | 43 |  |  |  |  |
Weighted-average shares outstanding—diluted | 97,439 |  | 97,047 |  |  |  |  |
Net income per share attributable to Dolby Laboratories, Inc.: |  |  |  |  |  |
Basic | $ | 0.70 |  | $ | 0.83 |  |  |  |  |
Diluted | $ | 0.69 |  | $ | 0.82 |  |  |  |  |
Antidilutive awards excluded from calculation: |  |  |  |  |  |
Stock options | 1,042 |  | 1,509 |  |  |  |  |
Restricted stock units | 36 |  | 350 |  |  |  |  |
Employee stock purchase plan | 95 |  | 10 |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration